Asia-Pacific Asparaginase Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Escherichia coli, Erwinia chrysanthemi, Pegylated, and Others), Application (Therapeutic, Food Processing, and Others), and End-use Industry (Healthcare and Food Manufacturing)

No. of Pages: 112    |    Report Code: BMIRE00027447    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia-Pacific Asparaginase Market

1.           Introduction  16

1.1         Study Scope. 16

1.2         The Insight Partners Research Report Guidance. 16

1.3         Market Segmentation. 18

1.3.1        APAC Asparaginase Market – By Type. 20

1.3.2        APAC Asparaginase Market – By Application. 20

1.3.3        APAC Asparaginase Market – By End-Use Industry. 20

1.3.4        APAC Asparaginase Market – By Country. 21

2.           Key Takeaways  22

3.        Research Methodology  25

3.1         Coverage. 26

3.2         Secondary Research. 27

3.3         Primary Research. 27

4.           APAC Asparaginase Market – Market Landscape  29

4.1         Overview.. 29

4.2         APAC PEST Analysis. 29

4.3         Experts Opinion. 31

5.           APAC Asparaginase Market – Key Market Dynamics  32

5.1         Market Drivers. 32

5.1.1        Rising Incidences of Leukemia and Increasing Usage Application. 32

5.1.2        Significant Growth of Pharmaceutical and Food Industry. 32

5.2         Market Restraints. 33

5.2.1        Side Effects Associated With Use of Asparaginase. 33

5.3         Market Opportunities. 33

5.3.1        New Product Launches and Approvals. 33

5.4         Future Trends. 34

5.4.1        Increase in R&D Activities and Investment by Market Players. 34

5.5         Impact Analysis. 35

6.           Asparaginase Market– APAC Analysis  36

6.1         APAC Asparaginase Market Revenue Forecasts and Analysis. 36

7.           APAC Asparaginase Market Analysis – By Type  38

7.1         Overview.. 38

7.2         By Type: APAC Market Revenue and Forecast Analysis (US$ Million) 38

7.2.1        Escherichia Coli 39

7.2.1.1          Overview.. 39

7.2.1.2          Escherichia coli Market Revenue and Forecast to 2028 (US$ Million) 39

7.2.2        Erwinia Chrysanthemi 40

7.2.2.1          Overview.. 40

7.2.2.2          Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million) 40

7.2.3        Pegylated. 41

7.2.3.1          Overview.. 41

7.2.3.2          Pegylated Market Revenue and Forecast to 2028 (US$ Million) 41

7.2.4        Others. 42

7.2.4.1          Overview.. 42

7.2.4.2          Others Market Revenue and Forecast to 2028 (US$ Million) 42

8.           APAC Asparaginase Market Analysis – By Application  43

8.1         Overview.. 43

8.2         By Application: APAC Market Revenue and Forecast Analysis (US$ Million) 43

8.2.1        Therapeutic. 44

8.2.1.1          Overview.. 44

8.2.1.2          Therapeutic Market Revenue and Forecast to 2028 (US$ Million) 44

8.2.1.3          Acute Lymphoblastic Leukaemia (ALL) 45

8.2.1.3.1          Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million) 45

8.2.1.4          Lymphoblastic Lymphoma (LBL) 46

8.2.1.4.1          Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million) 46

8.2.1.5          Others. 47

8.2.1.5.1          Others Market Revenue and Forecast to 2028 (US$ Million) 47

8.2.2        Food Processing. 48

8.2.2.1          Overview.. 48

8.2.2.2          Food Processing Market Revenue and Forecast to 2028 (US$ Million) 48

8.2.3        Others. 49

8.2.3.1          Overview.. 49

8.2.3.2          Others Market Revenue and Forecast to 2028 (US$ Million) 49

9.           APAC Asparaginase Market Analysis – By End-use Industry  50

9.1         By End-Use: APAC Market Revenue and Forecast Analysis (US$ Million) 50

9.1.1        Healthcare. 51

9.1.1.1          Overview.. 51

9.1.1.2          Healthcare Market Revenue and Forecast to 2028 (US$ Million) 51

9.1.2        Food Manufacturing. 53

9.1.2.1          Overview.. 53

9.1.2.2          Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million) 53

10.        APAC Asparaginase Market – Country Analysis  54

10.1      Overview.. 54

10.1.1     APAC: Asparaginase Market, by Country, 2021 & 2028 (%) 56

10.1.1.1       China Asparaginase Market Revenue and Forecasts to 2028 (US$ Million) 56

10.1.1.1.1       Overview.. 56

10.1.1.1.2       China: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 57

10.1.1.1.3       China: Asparaginase Market, by Type, 2019–2028 (US$ Million) 58

10.1.1.1.4       China: Asparaginase Market, by Application, 2019–2028 (US$ Million) 58

10.1.1.1.4.1     China Asparaginase Market, by Therapeutic Application – 2020 - 2028 (US$ Million) 59

10.1.1.1.5       China: Asparaginase Market, by End-User, 2019–2028 (US$ Million) 59

10.1.1.2       Japan Asparaginase Market Revenue and Forecasts to 2028 (US$ Million) 60

10.1.1.2.1       Overview.. 60

10.1.1.2.2       Japan: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 61

10.1.1.2.3       Japan: Asparaginase Market, by Type, 2019–2028 (US$ Million) 62

10.1.1.2.4       Japan: Asparaginase Market, by Application, 2019–2028 (US$ Million) 62

10.1.1.2.4.1     Japan: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 63

10.1.1.2.5       Japan: Asparaginase Market, by End-User, 2019–2028 (US$ Million) 63

10.1.1.3       India Asparaginase Market Revenue and Forecasts to 2028 (US$ Million) 64

10.1.1.3.1       Overview.. 64

10.1.1.3.2       India: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 65

10.1.1.3.3       India: Asparaginase Market, by Type, 2019–2028 (US$ Million) 66

10.1.1.3.4       India: Asparaginase Market, by Application, 2019–2028 (US$ Million) 66

10.1.1.3.4.1     India: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 67

10.1.1.3.5       India: Asparaginase Market, by End-User, 2019–2028 (US$ Million) 67

10.1.1.4       Australia Asparaginase Market Revenue and Forecasts to 2028 (US$ Million) 68

10.1.1.4.1       Overview.. 68

10.1.1.4.2       Australia: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 69

10.1.1.4.3       Australia: Asparaginase Market, by Type, 2019–2028 (US$ Million) 70

10.1.1.4.4       Australia: Asparaginase Market, by Application, 2019–2028 (US$ Million) 70

10.1.1.4.4.1     Australia: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 71

10.1.1.4.5       Australia: Asparaginase Market, by End-User, 2019–2028 (US$ Million) 71

10.1.1.5       South Korea Asparaginase Market Revenue and Forecasts to 2028 (US$ Million) 72

10.1.1.5.1       Overview.. 72

10.1.1.5.2       South Korea: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 73

10.1.1.5.3       South Korea: Asparaginase Market, by Type, 2019–2028 (US$ Million) 74

10.1.1.5.4       South Korea: Asparaginase Market, by Application, 2019–2028 (US$ Million) 74

10.1.1.5.4.1     South Korea: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 75

10.1.1.5.5       South Korea: Asparaginase Market, by End-User, 2019–2028 (US$ Million) 75

10.1.1.6       Rest of APAC Asparaginase Market Revenue and Forecasts to 2028 (US$ Million) 76

10.1.1.6.1       Overview.. 76

10.1.1.6.2       Rest of APAC: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 76

10.1.1.6.3       Rest of APAC: Asparaginase Market, by Type, 2019–2028 (US$ Million) 77

10.1.1.6.4       Rest of APAC: Asparaginase Market, by Application, 2019–2028 (US$ Million) 78

10.1.1.6.4.1     Rest of APAC: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 78

10.1.1.6.5       Rest of APAC: Asparaginase Market, by End-User, 2019–2028 (US$ Million) 79

11.        Industry Landscape  80

11.1      Overview.. 80

11.2      Inorganic Growth Strategies. 80

11.2.1     Overview.. 80

11.3      Organic Growth Strategies. 82

11.3.1     Overview.. 82

12.        Company Profiles  83

12.1      Servier Pharmaceuticals LLC. 83

12.1.1     Key Facts. 83

12.1.2     Business Description. 83

12.1.3     Products and Services. 84

12.1.4     Financial Overview.. 84

12.1.5     SWOT Analysis. 86

12.1.6     Key Developments. 87

12.2      Biovendor, LLC. 88

12.2.1     Key Facts. 88

12.2.2     Business Description. 88

12.2.3     Products and Services. 89

12.2.4     Financial Overview.. 89

12.2.5     SWOT Analysis. 89

12.2.6     Key Developments. 90

12.3      Creative Enzymes. 91

12.3.1     Key Facts. 91

12.3.2     Business Description. 91

12.3.3     Products and Services. 92

12.3.4     Financial Overview.. 92

12.3.5     SWOT Analysis. 93

12.3.6     Key Developments. 93

12.4      Taj Pharmaceuticals Limited. 94

12.4.1     Key Facts. 94

12.4.2     Business Description. 94

12.4.3     Products and Services. 95

12.4.4     Financial Overview.. 95

12.4.5     SWOT Analysis. 96

12.4.6     Key Developments. 96

12.5      medac GmbH.. 97

12.5.1     Key Facts. 97

12.5.2     Business Description. 97

12.5.3     Products and Services. 98

12.5.4     Financial Overview.. 98

12.5.5     SWOT Analysis. 99

12.5.6     Key Developments. 100

12.6      Jazz Pharmaceuticals, Inc. 101

12.6.1     Key Facts. 101

12.6.2     Business Description. 101

12.6.3     Products and Services. 101

12.6.4     Financial Overview.. 102

12.6.5     SWOT Analysis. 104

12.6.6     Key Developments. 105

12.7      Changzhou Qianhong Biopharma Co Ltd. 106

12.7.1     Key Facts. 106

12.7.2     Business Description. 106

12.7.3     Products and Services. 106

12.7.4     Financial Overview.. 106

12.7.5     SWOT Analysis. 107

12.7.6     Key Developments. 107

12.8      United Biotech (P) Limited. 108

12.8.1     Key Facts. 108

12.8.2     Business Description. 108

12.8.3     Products and Services. 108

12.8.4     Financial Overview.. 108

12.8.5     SWOT Analysis. 109

12.8.6     Key Developments. 109

13.        Appendix  110

13.1      About The Insight Partners. 110

13.2      Glossary of Terms. 110

 

 

LIST OF TABLES

Table 1.             APAC Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn) 37

Table 2.             China Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 58

Table 3.             China Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 58

Table 4.             China Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 59

Table 5.             China Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million) 59

Table 6.             Japan Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 62

Table 7.             Japan Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 62

Table 8.             Japan Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 63

Table 9.             Japan Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million) 63

Table 10.          India Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 66

Table 11.          India Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 66

Table 12.          India Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 67

Table 13.          India Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million) 67

Table 14.          Incidence, Mortality and Prevalence by cancer site, Australia, 2018. 68

Table 15.          Australia Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 70

Table 16.          Australia Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 70

Table 17.          Australia Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 71

Table 18.          Australia Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million) 71

Table 19.          South Korea Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 74

Table 20.          South Korea Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 74

Table 21.          South Korea Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 75

Table 22.          South Korea Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million) 75

Table 23.          Rest of APAC Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 77

Table 24.          Rest of APAC Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 78

Table 25.          Rest of APAC Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 78

Table 26.          Rest of APAC Asparaginase Market, by End-Use – Revenue and Forecast to 2028 (US$ Million) 79

Table 27.          Recent Inorganic Growth Strategies. 80

Table 28.          Recent Organic Growth Strategies. 82

Table 29.          Glossary of Terms. 110

 

 

LIST OF FIGURES

Figure 1.           APAC Asparaginase Market Segmentation. 18

Figure 2.           APAC Asparaginase Market Segmentation, by Country. 19

Figure 3.           APAC Asparaginase Market Overview.. 22

Figure 4.           APAC Asparaginase Market, By Type. 23

Figure 5.           APAC Asparaginase Market, By Country. 24

Figure 7.           APAC: PEST Analysis. 30

Figure 8.           Experts Opinion. 31

Figure 9.           APAC Asparaginase Market Impact Analysis of Drivers and Restraints. 35

Figure 10.        APAC Asparaginase Market – Revenue Forecasts and Analysis. 36

Figure 11.        By Type: APAC Market Analysis and Forecast 2021 and 2028 (%) 38

Figure 12.        APAC Escherichia coli Market Revenue and Forecast to 2028 (US$ Million) 39

Figure 13.        APAC Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million) 40

Figure 14.        APAC Pegylated Market Revenue and Forecast to 2028 (US$ Million) 41

Figure 15.        APAC Others Market Revenue and Forecast to 2028 (US$ Million) 42

Figure 16.        By Application: APAC Market Analysis and Forecast 2021 and 2028 (%) 43

Figure 17.        APAC Therapeutic Market Revenue and Forecast to 2028 (US$ Million) 44

Figure 18.        APAC Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million) 45

Figure 19.        APAC Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million) 46

Figure 20.        APAC Others Market Revenue and Forecast to 2028 (US$ Million) 47

Figure 21.        APAC Food Processing Market Revenue and Forecast to 2028 (US$ Million) 48

Figure 22.        APAC Others Market Revenue and Forecast to 2028 (US$ Million) 49

Figure 23.        By End-Use: APAC Market Analysis and Forecast 2021 and 2028 (%) 50

Figure 24.        APAC Healthcare Market Revenue and Forecast to 2028 (US$ Million) 52

Figure 25.        APAC Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million) 53

Figure 26.        APAC: Asparaginase Market, by Key Country – Revenue (2021) (US$ Million) 55

Figure 27.        APAC: Asparaginase Market, by Country, 2021 & 2028 (%) 56

Figure 28.        China: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 57

Figure 29.        Japan: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 61

Figure 30.        India: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 65

Figure 31.        Australia: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 69

Figure 32.        South Korea: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 73

Figure 33.        Rest of APAC: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 77

 

The List of Companies - Asia-Pacific Asparaginase Market

  1. Biovendor, LLC
  2. Changzhou Qianhong Biopharma Co Ltd
  3. Creative Enzymes
  4. Jazz Pharmaceuticals, Inc.   
  5. medac GMBH    
  6. Servier Pharmaceuticals LLC
  7. Taj Pharmaceuticals Limited    
  8. United Biotech (P) Limited